![](https://news.europawire.eu/wp-content/uploads/2024/07/EIB-Invests-E37.5-Million-in-Nyxoahs-Innovative-Sleep-Apnea-Solutions-144x144.jpg)
(IN BRIEF) The European Investment Bank (EIB) has awarded Belgium-based medtech company Nyxoah €37.5 million in venture-debt financing to support the development of innovative treatments for obstructive sleep apnea (OSA). This funding, backed by the InvestEU Life Sciences programme, will … Read the full press release